The course ofacinic cell carcinoma oftheparotidglandfollowing surgical and nonsurgical interventions is variable . The objective ofthis study was to report our experience in treating this disease and to evaluate thefactors that might be involved in the treatment of the tumor and the prognosis of the patient. To limit the contributory variables that are usually found in most studies, we included only those patients (n = 11) who had been treated by a single surgeon at a single institution from 1988 through 2003. Hospital and office recordswere evaluatedfordemographic information, signs and symptoms, treatment modalities, pathology, and outcomes. Additionalfollow-up data were obtained through telephone interviews. For the most part, treatment included either superficial parotidectomy or total parotidectomy with facial nerve preservation; 1 patient with coexisting adenocarcinoma underwent a more radical procedure, and 4 patients underwent adjuvant radiation therapy. The most prevalent morphologic pattern ofthese tumors was microcystic. Follow-up rangedfrom 1year and 3 months to 10 years and 9 months (mean: 4 yr and 11 mo). During that time, we found no recurrences ofacinic cell carcinoma and no evidence of metastatic disease. Therefore, we conclude that acinic cell carcinoma can be successfully treated with a superficial or total parotidectomy with sparing of the facial nerve. Radiation therapy may provide adjunctive benefit. Volume 84, Number 9 * Patient 8 had coexisting adenocarcinoma and acinic cell carcinoma. The adenocarcinoma recurred 2 years postoperatively and metastasized.
Introduction
Acinic cell carcinoma is a relatively uncommon malignancy, accounting for 1 to 6% of all salivary gland tumors and 15% of all malignant tumors of the parotid gland.P It is the fourth most common malignant salivary gland tumor, following mucoepidermoid carcinoma, adenoid cystic carcinoma, and carcinoma ex pleomorphic adenoma; it occurs more frequently than primary squamous cell carcinoma.i" With regard to the prevalence of parotid gland cancers in children, acinic cell carcinoma is second only to mucoepidermoid carcinoma.Y Most acinic cell carcinomas occur between the ages of 40 and 49 years ."? Ellis and Corio reported that the tumor is most common among whites (90% of cases); blacks account for 8% of cases." It affects twice as many females as males."! Acinic cell carcinomas of the parotid gland occur bilaterally in 3% of cases, a rate of bilaterality that is second only to that ofWarthin's tumor. 2 ,5,6,9Acinic cell carcinomas rarely occur in the minor salivary glands.'
The results of treating acinic cell carcinoma are quite variable. Local recurrences have been reported in 8 to 56% of patients, but the recurrence rate rarely exceeds 20%. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Reported rates oflymph node and distant metastases range from 0 to 16%, but most are less than 10%. 5, 8, [10] [11] [12] [13] [14] [15] [16] Mortality from the disease is usually less than 10% at 5 years, but by 20 years it has been reported to be as high as 50%. [4] [5] [6] [7] 9, 17 Most published series of patients with acinic cell carcinoma are limited, and they represent the experiences of institutions rather than individual surgeons. Therefore, it is not possible to know for certain if the high degree of variability in treatment outcomes is associated with variations in tumor characteristics or with variations in different treatment strategies. With that in mind, we conducted a study of a series of patients with acinic cell carcinoma who were treated at one institution by one surgeon in an attempt to reduce these variabilities.
Patients and methods
We reviewed medical records from the Harper University Hospital and identified those patients who had been operated on by the senior author (R.H .M .) for acinic cell carcinoma of the parotid gland from 1988 through 2003. We noted each patient's sex and age and the site and size ofthe tumor (table 1) ; type of treatment, involvement at the surgical margins, and the tumors' histologic patterns (table 2); and  postoperative complications, adjuvant therapy, and the  duration of follow-up (table 3) . We also assessed tumors for the presence of perineural and/or vascular invasion and metastasis. For those patients who were eventually lost to follow-up, information regarding recurrence and metastasis was obtained through telephone interviews.
In all, 11 patients-3 males and 8 females (10 whites and 1 black) , aged 14 to 73 years (mean: 43.4)-were included in this review.
Case summaries
Patient 1. A 61-year-old white man presented with a recurrent 0.6-cm lesion of the left superficial parotid gland . Eight years earlier, he had developed facial swelling near the left parotid gland, and a 3.2-cm lesion was detected in the left superficial lobe. At that time , he underwent superficial parotidectomy at another institution, and he had remained disease-free since.
The senior author treated the 0.6-cm recurrence with a total parotidectomy with sparing of the facial nerve. No signs of metastatic disease were evident, and the surgical margins were negative. Histologically, the lesion was predominately microcystic in structure . Postoperatively, the patient experienced transient weakness of the left comer of the mouth and a mild depression on the left side of the face. Because he had already experienced one recurrence, he was administered 3,000 cOy ofradiation to the surgical bed. There was no recurrence during 3 years and 7 months of follow-up.
Patient 2. A 32-year-old white woman presented with facial swelling and pain in the right parotid gland. A 3em lesion was detected in the right superficial lobe, and a superficial parotidectomy was performed. Marg ins were negat ive, and there was no evidence of metastatic disease. Histologically, the structure ofthe lesion was predominately microcystic. Postoperatively, she experienced transient weakness of the right face and a mild depression at the surgical site. There was no evidence of Frey's syndrome. No recurrence was evident at 2 years and 6 months .
Patient 3. A 46 -year-old white man presented with facial swelling and tenderness of the left parotid gland. The lesion measured 2 em in the deep lobe of the gland . He underwent a total parotidectomy with sparing of the facial nerve . Margins were negative and there was no evidence of metastatic disease. Histologically, the lesion was predominantly microcystic . Postoperatively, he experienced transient weakness of the left side of the lip. He also had a mild depression at the surgical site. No Frey's syndrome was present. There was no recurrence at 2 years and 6 months.
Patient 4. A 58-year-old white woman was evaluated for facial swelling near the left parotid gland . A I-em lesion was found in the superficial lobe . Her treatment was a superficial parotidectomy. Margins were negative, and 598 there was no evidence ofmetastatic disease . Histologically, the lesion was predominantly papillary cystic in structure. Postoperatively, she had transient facial weakness near the left eye. There was a mild depression at the surgical site, and no evidence of Frey's syndrome. There was no recurrence at 5 years and 10 months .
Patient 5. A 41-year-old white woman presented with facial swelling of the left parotid gland , the result of the recurrence of an acinic cell carcinoma that had first arisen more than 10 years earlier. At that time, she underwent a left superficial parotidectomy for removal of the primary tumor. However, the surgical margin was positive.
The 0.9-cm recurrent mass was excised during a total parotidectomy with sparing of the facial nerve and a left modified neck dissection. The margins were negative, and there was no evidence ofmetastatic disease. Histologically, the lesion was predominantly microcystic in structure. Postoperatively, there was no facial weakness, a mild facial depression, and no complaints of gustatory sweating. In light of her initial positive margin, she underwent 2,160 cOy ofradiation therapy to the parotid area . There was no recurrence during a follow-up of 6 years and 10 months. Patient 6. A 16-year-old white boy was referred to us 1 month after he had undergone a superficial parotidectomy at another institution for removal of a mass in the left superfic ial lobe. When facial swelling persisted, he was referred to Harper University Hospital. During our examination, a residual 1.3-cm lesion was found to extend to the surgical margin of the resection. We performed a total parotidectomy with facial nerve sparing. No cancer was found in the parotidectomy specimen itself, and histologically, the original lesion was predominantly microcystic in structure. Postoperatively, the patient exhibited transient upper facial weakness, mild facial depression, and no evidence of Frey's syndrome. Considering his age, no adjuvant radiation therapy was initiated . No recurrence was evident at 7 years and 6 months.
Patient 7. A 41-year-old white woman presented with facial swelling. A 2-cm lesion was identified in the left deep lobe of the parotid gland. She underwent a total parotidectomy with sparing ofthe facial nerve. Aplatysma/ sternocleidomastoid muscle flap was used to reconstruct the defect. The tumor extended near the margin of the resection, but no signs of metastasis were found. Histologically, the lesion was predominantly solid in structure. Postoperatively, the patient exhibited no facial weakness and a mild facial depression on the side of the surgery. Because the tumor was very close to the margin of the resection, she was administered 5,400 cOy of radiation therapy to the surgical site. There was no recurrence at 7 years and 8 months. Histo logically, the lesion was of the microcystic variety. Postoperatively, the patient experienced no weakne ss ofthe face and no facial depression. Adj uvant radiation therapy was consi dere d, but in view of the patient 's young age and the relatively benign course of these tumors , a conservative wait -and -watch approach was adopted. No signs of recurrence were observed during 2 years and 8 months of close follow-up .
Patient 11. A38-year-old black woman presented wit h a 6-month history ofa tender right facial mass. She reported that 20 years earlier, she had undergone a superficial parot idectomy for removal of an acin ic cell carcinoma of the left parotid. Her new mass measured 1.5 em and was noted in the right tail ofthe parotid gland . She was treated with a right total parotidectomy with facial nerve spar ing. Histo logically, the tumor was ofthe solid var iety. The margins were nega tive, and there were no signs of metastasis. Postoperatively, the patient exhibited no facial weakness and no facia l depress ion. No signs of a recurrence were observed during 1 year and 3 months of follow-up. 
Res ults
The most common presenting symp tom in this series was fac ial swe lling. Six of the tumors were located in the left parotid and five on the right. Eight of the 11 tumo rs we re located in the superficial lobe ofthe parotid and 3 in the deep lobe. Tumors ranged in size from 0.6 to 3.2 em. Three of the tumors were recurrent or residua l lesions (tab le 1).
Preoperative evaluations included computed tomography with contrast for all patients, fine-need le asp iration biopsy (FNAB) for 10, and magnetic resonance imaging for a few. One patie nt refused FNAB , but in the other 10, its predictive va lue was quest ionab le, as only 5 of the 10 FNA Bs correctly identifie d the acinic cell carci noma .
In our series, only 1 patient had experienced bilatera l disease (patient 11); she had developed left-sided disease 20 years prior to presenting to us with right-sided disease. Anot her patient had both an adenocarcinoma and an acinic ce ll carcinoma within the same parotid gland (patient 8).
Histo logically, 7 tumors were of the microcystic type, 2 were papi llary cyst ic, and 2 were solid. In 3 patients, surgical margi ns were pos itive after resect ion at our institution (table 2) .
There were no cases of perineura l or vascular invasion or metastasis.
Superficial parotidectomy was the initial treatment for acinic cell carcinoma in 7 of these patients, including the 3 who had been initially treated at other institutions. Three patients with deep-lobe tumors were treated with a total parotidectomy, and the 1patient who had a coexisting adenocarcinoma underwent a radical paro tidectomy. Three adenocarcinoma, and she was referred to our institution. On exam ination , we identified a 2.5-cm mass in the deep lobe of the right parot id. The senior author performed a radica l parotidectomy, a comp lete neck dissection , and a mastoidectomy with facial nerve resection and nerve grafti ng. The final patho logic examination of the parotid revea led the presence of both an adenocarcinoma and an acinic cell carcinoma.The margins were positive forcancer, but no dista nt metastasis was discovered. Histologica lly, the acinic cell tumor featured a microcystic cribriform pattern. Postoperatively, the patient exhibited a comp lete loss of right facia l function and a moderate depress ion of the tissues of the right face. In view of the presence of both an adenocarcinoma and an acinic cell carcinoma at the surgical margi ns, she underwent 3,000 cGy ofradiation therapy and 3 courses ofchemotherapy with 5-fluorouracil and cisp latin um . However, the adenocarcinoma rec urred 2 years later and metastasized to the neck and lung; the acinic cell carcinoma did not recur. The patient died of adenocarcinoma 3 years following resec tion.
Patient 9. A 73-year-old white woman presented with facial swell ing and pain . A 1.5-cm tumor was locate d in the right superficial lobe ofthe parotid, and she underwent a right superficial paro tidectomy. The margins were positive , but there were no signs of metastatic disease. Histologically, the lesion was of the papillary cystic var iety. Postoperatively, the fronta l branch of the fac ial nerve on the right side of the face was weak, but there was no facia l depression. Even with the positive margins , the patient did not wish to undergo any further treatment. During 10 years and 9 months of close follow-up , no signs of rec urrence were evide nt.
Patien t 10. A 14-year-old white girl presented with right facial swe lling that had bee n present for several years. A tumor measuring 2 em was found in the right tail of the parotid, and she underwent a superficial paroti dectomy. The margins were positive next to the trunk of the faci al nerve, but there were no signs of metastat ic disease . patients who had either a positive margin or a recurrence following a superficial parotidectomy laterrequired salvage total parotidectomy. It is interesting that the 3 patients who we treat ed for either recu rrent or residual disease all had the microcystic form of the tumor.
Follow-up ranged from I year and 3 months to 10 years and 9 months (mean: 4 yrand I I mo ). None ofour patients developed a recurrence or met ast asis following final treatment. Four patients underwent adjuvant rad iation therapy because they had either recurrent disease (patients I and 5), tumor extension up to the surgical margin (patient 7), or a positive surgical margin (pati ent 8). Another patient had a positive surgical margin next to the facia l nerve trunk (patient 10), but in view of her young age (14 yr), the radiotherapist recommended against radiation therapy. One patient req uested that radiation therapy be discontinued after she had received 2,160 cOy (patient 5). Finally, the pat ient who had a concomitant adenocarcinoma (patient 8) received chemotherapy in addition to rad iation therapy (table 3) .
Postoperatively, transient facial we akne ss was seen in 6 patients and a complete loss of facial muscle function was seen in 1. Eight patients had some form of facial (table 3) .
D iscussio n
Our find ings support the view that acinic cell carcinoma can occur at any age (as early as 14 yr) but that it is more common among patients in midlife." We also found a predisposition toward whites and females.:" As reported by others, we found that the tum or usually appeared as a pain less mass in either the superficial or deep lobe of the parotid gland. 3 • 5 • 6 ,8, 17 As was the case in our study, patients do not usually present with facia l weakness. 3 ,5.6,8, 17 One of the controversies surrounding acinic ce ll carcinoma is its ma lignant pote ntia l. Prognostic var iables include traditional considera tions such as tumor site , size, and histologic growth pattern, as well as the presence or absence ofmetastasis. In our series, tumor size ranged from 0.6 to 3.2 em. According to Timon et ai, large tumors (e.g ., 2.92 em) carry a worse prognosis than do small tumors (e .g., 1.93 em ).'?
According to Batsakis et ai, acinic cell carcinomas are deri ved from the intercalated ducts of the salivary duct and tubul ar system. " Th e tumor can be muitifocal in Microcystic Solid origin and arise bilaterally, which wou ld account for its simi larity to Warth in's tumor; one of our pat ients (patient 11) experience d bilateral tumo rs, which manifested 20 years apart. According to Batsakis and co lleagues, acinic cell carcinomas develop in seven histologic patterns: acinar-lobular, microcystic, fo llicular, papillary cystic, medullary, ductoglandula r, and primitive tubu lar.i-" Ellis an d Corio developed a simp ler sys tem ofthree categories: cys tic pap illary, follicular, and solid." However, neither of these sys tems apparently correlates well with the biolog ic course ofthe tumor. Timon et al reported that so lid tumors are associated with the worst prognosis." Only 2 of our patients had solid tumors (patients 7 and II), and neither recurred, altho ugh one ofthese patients (patient I I) subsequently developed a tumor on the other side. Seven of the patients in our ser ies had microcystic tumors, 3 of whom had presented with recurrent or residual disease. None of these patients developed a recurrence after treatment at our institution. Batsakis proposed a two -part (high-grade and low-grade) staging system in which the character istics of high-grade tumors included intravascular exte nsion, fingerl ike invasion, and medullary, ductoglandul ar, or primitive tubu lar foci.' However, he conceded that such a classification sys tem was not without shortcomings. 2 By Batsakis's standards, none of the tumors in our series we re high-grade. Eneroth and colleagues reported a correlation between the invasiveness of acinic ce ll carcinoma and the quantitation of DNA, but they observed that this relationship did not necessarily predict the patient's clinical course.r-"
This "ambiguity over the ma lignancy of ac inic ce ll neoplasm," as Batsakis-wrote in 1979, poses difficulties in our attempts to determin e optimal treatment strategies. In the 1960s, Eneroth and colleagues 19.21 suggested that the malignant potent ial ofacinic cell carcinoma is significant, but this was no tevident in our experience. Those investigators who be lieve that the tumor is indeed malignant have recommended the most agg ressive form oftreatment-that is, tota l parotidectomy and neck dissection.19-21 On the other hand, Goodwin et al were not convinced of the maligna nt potential ofthis tumor, and they recommended conservative management and excision of the tumor with a marg in of the parotid gland." Enucleation shou ld not be performed because it has bee n associated with some ofthe hig h rec urrence rates that have been reported.i-"
Our experience supports the idea of complete extirpative surgery as definitive, an d we do not advocate radical procedures. We suggest that the fai lure of an initial superficial parotidectomy to eradicate the tumor is pro bab ly attributa ble to an insufficient margin of norm al tissue. It seems to us that an adequate superficial parotidectomy with sparing of the facia l nerve sho uld be quite effective in removing a tumor in the superficial lobe. Conversely, a tota l parotidectomy appears to be necessary for recurrent tumors and for primary tumors located in the deep lobe. Radical parotidectomy with removal ofthe facia l nerve, as proposed by Grage et aP3in 196 1, appears to be adv isab le only when a pat ient has ano ther aggressive malignancy, as did our patient who had a coexisting adenocarcinoma (patient 8) .
The role ofrad iation therapy has not been fully eva luated. Batsakis an d others have suggested that acinic cell carcinoma is re latively rad iosensitive and that external rad iation therapy should be considered for loca lly advanced tumors, late-stage disease, and residual lesions.s" :" Some authors have co ntended that adjuvant rad iation therapy prov ides only limited benefit against small supe rficial tumors .e' :" Others have sug gested that radiation therap y is indicated for acinic cell carcinoma in cases of (I) recurrent tumors, (2) equ ivocal or positive margins or tumo r spillage, (3) tumors adjacent to the facial nerve, (4) deep-lob e involvement , (5) lymph node metastases , (6) extraparotid extensions , and (7) large tumo rs (>4 cm).3.27.28In our series, we tended to reserve external radiation therapy for patients with positi ve margins or a history of recurrence . Two patients received rad iation therapy after surgical resection of locally recurrent disease (patients I and 5), I patient recei ved radiation therapy for extension of disease to near the surgic al margin (patient 7), and I patient rece ived both radiation and chemotherapy for positi ve marg ins and the presence of coexisting adenocarcinoma (patient 8). None experienced a recurrence of acinic cell carcinoma. In view ofthe low incidence ofmetastasis (_10 %),5.8.1 0-16 elective neck dissection does not appear to be warranted. The senior author performed a selective neck dissection on patient 8 because we believed that she possibly had a metastas is.Obv iously, iflymph node positivity is suggested by imaging studies or is otherwise susp ected , the surgeon can sample the node s and perform a neck dissection when indicated.
Although we restricted our series to the expe rienc e of a single surgeon at a single instituti on-and thereby reduced operative and outcome variability-our results must be interpreted with caut ion. The size of our series was small, and our follow-up period was relatively short, ranging from I year and 3 months to 10 years and 9 months (mean: 4 yr and II mo) . Other authors have maintained that a follow-up ofat least 20 years is necessary to adequ ately determine final treatment outcomes.'!' Long -term follo w-up is necess ary because cure rates at 5, 10, and 15 years declin e from 76% to 63% to 44%, respectively.l-" In their review of II cases , Grage et al reported that the 4 patients who died of acinic cell carcinoma survived an average of 13 years follow ing diagnos is and treatment. " Batsakis also reported that death can occur after a significant length of time.' Anothe r limitation of our study is that we did not study a selected group of patients whose prognos es were necessarily good. In fact , 3 of our patient s had already been treated for previous disease , and 4 others had positi ve or near-positive margins.
In summary, acinic cell carcinoma is considered to be a low-grade malignancy without well-de fined predictors of local or regional recurrence or metastasis. Patients treated with superficial or total parot idectomy with facial nerve sparing, either as the initial therapy or as salva ge therap y, appear to survive with little if any recurrence. Postoperatively, pat ients may experience temporary facial weakness, but this morbidity appears to be insignificant comp ared with the overall benefit of reduc ing the risk of recurrence and its associated morbidity and mortality. Some patients may benefit from adju vant radiation therap y. 602 Even thou gh our findin gs are limited by the short duration of follow-up , we belie ve they suppo rt the effectiveness of our treatment strategy.
